We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

European Parliament Passes Pharmaceutical Regulatory Reform

Law360 (December 17, 2003, 12:00 AM EST) -- The European Parliament adopted sweeping new legislation Wednesday aimed at standardizing regulatory data protection for drugs across the European Union.

Under intense pressure from lobbyists for research-based and generic drug makers, the European Parliament reached a compromise for regulatory data protection known as “8+2+1,” under which new drugs will receive 10 years of protection from generic competition, including eight years of data protection, plus an additional year for new uses.

A final approval of the new regulatory environment by European Union ministers is expected in the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.